|
Office
of Inspector General Releases Two 340B-related Reports;
Withdraws One
Two recent
reports from the Department of Health and Human Services
Office of Inspector General (OIG) focused on the administration
of the 340B Drug Discount Program and prices paid
by covered entities for drugs.
View
all federal 340B
policy issues.
Since the beginning of the year, a number of states
have introduced legislation to promote use of the
340B Drug Pricing Program. It remains to be
seen which bills will become law, but the number of
states that have introduced 340B-related legislation
in 2005 indicates an increased awareness by state
lawmakers of the need to fully utilize the 340B Drug
Pricing Program.
View all
current state activity.
Updated
as of May 6, 2005
This section contains news
links to Medicare news as well as information on the
Medicare Prescription Drug, Improvement and Modernization
Act (MMA) and a link to CMS MMA updates.
View all
Medicare policy activity.
Office
of Pharmacy Affairs Studies and Reports
Evaluation
of HRSA's Clinical Pharmacy Demonstration Projects
- Volume 1: Synthesis Report
Volume
II: Case Studies
The
PHS 340B Drug Pricing Program: Results of a survey
of Eligible Entities
Other
Studies and Reports
IOM
Report: Quality Through Collaboration: The Future
of Rural Health
Uninsured
and Underserved: The Health Care Experiences of Latinos
in the Nation's Capital
Doughnut
Holes and Price Controls
Closing
the Doughnut Hole: No Easy Answers
View all latest
developments in policy.
|
